145 related articles for article (PubMed ID: 32915649)
1. Potential mechanism underlying the effect of matrine on COVID-19 patients revealed through network pharmacological approaches and molecular docking analysis.
Peng W; Xu Y; Han D; Feng F; Wang Z; Gu C; Zhou X; Wu Q
Arch Physiol Biochem; 2023 Feb; 129(1):253-260. PubMed ID: 32915649
[TBL] [Abstract][Full Text] [Related]
2. Study on mechanism of matrine in treatment of COVID-19 combined with liver injury by network pharmacology and molecular docking technology.
Liu F; Li Y; Yang Y; Li M; Du Y; Zhang Y; Wang J; Shi Y
Drug Deliv; 2021 Dec; 28(1):325-342. PubMed ID: 33517789
[TBL] [Abstract][Full Text] [Related]
3. The mechanism and active compounds of semen
Wang Y; Gu W; Kui F; Gao F; Niu Y; Li W; Zhang Y; Guo Z; Du G
Food Nutr Res; 2021; 65():. PubMed ID: 34908920
[TBL] [Abstract][Full Text] [Related]
4. Study on the mechanism of treating COVID-19 with Shenqi Wan based on network pharmacology.
Ye XW; Deng YL; Zhang X; Liu MM; Liu Y; Xie YT; Wan Q; Huang M; Zhang T; Xi JH; Zhang JL
Drug Dev Ind Pharm; 2021 Aug; 47(8):1279-1289. PubMed ID: 34605344
[TBL] [Abstract][Full Text] [Related]
5. The pharmacological mechanism of Huashi Baidu Formula for the treatment of COVID-19 by combined network pharmacology and molecular docking.
Cai Y; Zeng M; Chen YZ
Ann Palliat Med; 2021 Apr; 10(4):3864-3895. PubMed ID: 33691446
[TBL] [Abstract][Full Text] [Related]
6. Network pharmacology, molecular docking integrated surface plasmon resonance technology reveals the mechanism of Toujie Quwen Granules against coronavirus disease 2019 pneumonia.
Ye M; Luo G; Ye D; She M; Sun N; Lu YJ; Zheng J
Phytomedicine; 2021 May; 85():153401. PubMed ID: 33191068
[TBL] [Abstract][Full Text] [Related]
7. Network pharmacology and experimental validation identify the potential mechanism of sophocarpine for COVID-19.
Zhang HX; Zhang X
J Med Microbiol; 2022 May; 71(5):. PubMed ID: 35622496
[No Abstract] [Full Text] [Related]
8. Network pharmacology and molecular docking analysis on molecular targets and mechanisms of Huashi Baidu formula in the treatment of COVID-19.
Tao Q; Du J; Li X; Zeng J; Tan B; Xu J; Lin W; Chen XL
Drug Dev Ind Pharm; 2020 Aug; 46(8):1345-1353. PubMed ID: 32643448
[TBL] [Abstract][Full Text] [Related]
9. Potential effect of Maxing Shigan decoction against coronavirus disease 2019 (COVID-19) revealed by network pharmacology and experimental verification.
Li Y; Chu F; Li P; Johnson N; Li T; Wang Y; An R; Wu D; Chen J; Su Z; Gu X; Ding X
J Ethnopharmacol; 2021 May; 271():113854. PubMed ID: 33513419
[TBL] [Abstract][Full Text] [Related]
10. Identifying potential pharmacological targets and molecular pathways of Meliae cortex for COVID-19 therapy.
Khan SA; Lee TKW
Front Immunol; 2023; 14():1128164. PubMed ID: 36817449
[TBL] [Abstract][Full Text] [Related]
11. Network pharmacology and molecular docking analysis on mechanisms of Tibetan Hongjingtian (
Wang L; Wang Y; Yang W; He X; Xu S; Liu X; He Y; Hu Q; Yuan D; Jin T
J Med Microbiol; 2021 Jul; 70(7):. PubMed ID: 34313585
[No Abstract] [Full Text] [Related]
12. Chemical composition and pharmacological mechanism of shenfu decoction in the treatment of novel coronavirus
Li X; Lin H; Wang Q; Cui L; Luo H; Luo L
Drug Dev Ind Pharm; 2020 Dec; 46(12):1947-1959. PubMed ID: 33054436
[TBL] [Abstract][Full Text] [Related]
13. Investigating the active compounds and mechanism of HuaShi XuanFei formula for prevention and treatment of COVID-19 based on network pharmacology and molecular docking analysis.
Wang J; Ge W; Peng X; Yuan L; He S; Fu X
Mol Divers; 2022 Apr; 26(2):1175-1190. PubMed ID: 34105049
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 induces "cytokine storm" hyperinflammatory responses in RA patients through pyroptosis.
Zheng Q; Lin R; Chen Y; Lv Q; Zhang J; Zhai J; Xu W; Wang W
Front Immunol; 2022; 13():1058884. PubMed ID: 36532040
[TBL] [Abstract][Full Text] [Related]
15. Network Pharmacology and Bioinformatics Analysis Identifies Potential Therapeutic Targets of Paxlovid Against LUAD/COVID-19.
Zhang W; Yang Z; Zhou F; Wei Y; Ma X
Front Endocrinol (Lausanne); 2022; 13():935906. PubMed ID: 36157452
[TBL] [Abstract][Full Text] [Related]
16. Connective tissue disease-related interstitial lung disease is alleviated by tripterine through inhibition of the PI3K/Akt, apoptosis, and TNF-α signalling pathways.
Zhu W; Wang Y; Liu C; Wu Y; Li Y; Wang Y
Front Pharmacol; 2022; 13():990760. PubMed ID: 36419618
[No Abstract] [Full Text] [Related]
17. Bioactive Components of
Yuan H; Liu L; Zhou J; Zhang T; Daily JW; Park S
J Med Food; 2022 Apr; 25(4):355-366. PubMed ID: 35438554
[TBL] [Abstract][Full Text] [Related]
18. Network pharmacology and molecular docking analysis reveals the mechanism of asiaticoside on COVID-19.
Huang J; Zhou X; Gong Y; Chen J; Yang Y; Liu K
Ann Transl Med; 2022 Feb; 10(4):174. PubMed ID: 35280425
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms revealed by network pharmacology of Xuebijing on the treatment of acute respiratory distress syndrome caused by novel coronavirus infection.
Tao P; Jiming L
Eur Rev Med Pharmacol Sci; 2022 Apr; 26(8):2651-2661. PubMed ID: 35503609
[TBL] [Abstract][Full Text] [Related]
20. Network analysis for elucidating the mechanisms of Shenfu injection in preventing and treating COVID-19 combined with heart failure.
Zhou W; Chen Z; Fang Z; Xu D
Comput Biol Med; 2022 Sep; 148():105845. PubMed ID: 35849948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
